These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22928276)

  • 21. Minimal transfusions: comment on "Surgical outcomes and transfusion of minimal amounts of blood in the operating room".
    Holcomb JB
    Arch Surg; 2012 Jan; 147(1):55-6. PubMed ID: 22250114
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effective Prevention of Acute Hemolytic Transfusion Reaction again by Blood Matching of in vitro Hemolytic Test].
    Tang CH; Zhang TX; Yang HC; Zhang ZJ; Yuan M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1194-1198. PubMed ID: 28823291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
    Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
    Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Situation and perspectives of blood transfusion in Mali.
    Ba A
    Med Sante Trop; 2018 May; 28(2):120-123. PubMed ID: 29997064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion.
    Cahill MR; Joyce S; O'Brien N; Casey M
    Vox Sang; 2003 Aug; 85(2):121-2. PubMed ID: 12925167
    [No Abstract]   [Full Text] [Related]  

  • 27. [HEMOLYTIC BLOOD TRANSFUSION REACTION AND CELLULAR IMMUNITY].
    VAN LOGHEM JJ
    Ned Tijdschr Geneeskd; 1964 Jan; 108():149-51. PubMed ID: 14135803
    [No Abstract]   [Full Text] [Related]  

  • 28. [Roundtables of SFTS Congress 2013: Needs, indications and safety of blood products; self-sufficiency in blood products].
    Hermine O; Lassale B; Morel P; Samama CM; Folléa G; Monsellier M; Noël S; Tissot JD; Lefrère JJ
    Transfus Clin Biol; 2014 Jun; 21(3):120-31. PubMed ID: 24906893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling the risk of transfusion-transmitted syphilis: a reconsideration of blood donation testing strategies.
    Jayawardena T; Hoad V; Styles C; Seed C; Bentley P; Clifford V; Lacey S; Gastrell T
    Vox Sang; 2019 Feb; 114(2):107-116. PubMed ID: 30565234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
    Moncharmont P; Quittançon E; Barday G; Benamara A;
    Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood transfusion: the silent epidemic.
    Spiess BD
    Ann Thorac Surg; 2001 Nov; 72(5):S1832-7. PubMed ID: 11722117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Réactions transfusionnelles].
    Chiaroni J
    Rev Prat; 2018 Nov; 68(9):1029-1033. PubMed ID: 30869366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe haemolytic transfusion reactions caused by apparently compatible red cells.
    KISSMEYER-NIELSEN F; JENSEN KB; ERSBAK J
    Br J Haematol; 1961 Jan; 7():36-41. PubMed ID: 13756420
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased destruction of compatible red cells.
    GOUDSMIT R; KRIJNEN HW
    Vox Sang; 1957 Oct; 2(5):357-61. PubMed ID: 13530902
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood policy and transfusion practice--India.
    Bray TJ; Prabhakar K
    Trop Med Int Health; 2002 Jun; 7(6):477-8. PubMed ID: 12031068
    [No Abstract]   [Full Text] [Related]  

  • 36. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Vox Sang; 2015 Apr; 108(3):243-50. PubMed ID: 25536173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemovigilance and the Notify Library.
    Whitaker BI; Strong DM; Gandhi MJ; Petrisli E
    Immunohematology; 2017 Dec; 33(4):159-164. PubMed ID: 29378148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on iso-antibodies against red cells, white cells and platelets as a cause of blood transfusion reactions.
    van LOGHEM JJ; van der HART ; ENGELFRIET CP; va de WIEL TW
    Bibl Haematol; 1962; 13():312-8. PubMed ID: 14466301
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood transfusion in total hip arthroplasty: guidelines to eliminate overtransfusion.
    McSwiney MM; O'Farrell D; Joshi GP; McCarroll SM
    Can J Anaesth; 1993 Mar; 40(3):222-6. PubMed ID: 8467544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation between hospitals in rates of reported transfusion reactions: is a high reporting rate an indicator of safer transfusion?
    Wiersum-Osselton JC; van Tilborgh-de Jong AJ; Zijlker-Jansen PY; van de Watering LM; Brand A; van der Bom JG; Schipperus MR
    Vox Sang; 2013 Feb; 104(2):127-34. PubMed ID: 22892067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.